Preclinical Characterization of Naturally Occurring Polyketide Cyclophilin Inhibitors from the Sanglifehrin FamilyMatthew A. Gregory, Barrie Wilkinson, Mahmood Piraee et al.|Antimicrobial Agents and Chemotherapy|2011Cited by 54
Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral InfectionMagnus J. Hansson, Matthew A. Gregory, Steven J. Moss et al.|Chemistry & Biology|2015Cited by 38
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effectsSirle Saul, Shirit Einav, Marwah Karim et al.|Journal of Clinical Investigation|2023Cited by 34
Sangamides, a new class of cyclophilin-inhibiting host-targeted antivirals for treatment of HCV infectionSteven J. Moss, Matthew A. Gregory, Michael Bobardt et al.|MedChemComm|2011Cited by 26
Design, synthesis, and lead optimization of piperazinyl-pyrimidine analogues as potent small molecules targeting the viral capping machinery of Chikungunya virusVerena Battisti, Thierry Langer, Julia Moesslacher et al.|European Journal of Medicinal Chemistry|2023Cited by 8